CDC6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.222440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.583600E-01
Normal-vs-Stage2
1.165990E-01
Normal-vs-Stage3
1.900980E-01
Normal-vs-Stage4
2.290600E-01
Stage1-vs-Stage2
4.480200E-01
Stage1-vs-Stage3
5.957600E-01
Stage1-vs-Stage4
8.176000E-01
Stage2-vs-Stage3
9.871800E-01
Stage2-vs-Stage4
4.018200E-01
Stage3-vs-Stage4
4.827400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.269440E-01
Normal-vs-AfricanAmerican
1.309960E-01
Normal-vs-Asian
1.187400E-01
Caucasian-vs-AfricanAmerican
8.317400E-01
Caucasian-vs-Asian
5.329200E-01
AfricanAmerican-vs-Asian
7.759600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.566250E-01
Normal-vs-Female
9.174000E-02
Male-vs-Female
8.614400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.029200E-01
Normal-vs-Age(41-60Yrs)
9.954500E-02
Normal-vs-Age(61-80Yrs)
1.493430E-01
Normal-vs-Age(81-100Yrs)
8.338400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.934210E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.836600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.721240E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.855400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.722600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.773800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.038200E-01
Normal-vs-Daily Drinker
1.457810E-01
Normal-vs-Weekly Drinker
1.867030E-01
Normal-vs-Occasional Drinker
8.449800E-02
Normal-vs-Social Drinker
1.544350E-01
Non Drinker-vs-Daily Drinker
3.846800E-01
Non Drinker-vs-Weekly Drinker
7.697000E-01
Non Drinker-vs-Occasional Drinker
8.032000E-01
Non Drinker-vs-Social Drinker
7.251200E-01
Daily Drinker-vs-Weekly Drinker
3.475600E-01
Daily Drinker-vs-Occasional Drinker
2.291000E-01
Daily Drinker-vs-Social Drinker
6.694600E-01
Weekly Drinker-vs-Occasional Drinker
9.307000E-01
Weekly Drinker-vs-Social Drinker
5.524400E-01
Occasional Drinker-vs-Social Drinker
5.177000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.371200E-01
Normal-vs-Grade 2
7.212200E-01
Normal-vs-Grade 3
7.522000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.824200E-02
Grade 1-vs-Grade 3
6.739100E-03
Grade 1-vs-Grade 4
6.371200E-01
Grade 2-vs-Grade 3
4.374600E-01
Grade 2-vs-Grade 4
7.212200E-01
Grade 3-vs-Grade 4
7.522000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.318200E-01
Normal-vs-NonDiabetic
1.187820E-01
Diabetic-vs-NonDiabetic
2.001000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.517800E-02
Normal-vs-NoPancreatitis
1.620590E-01
Pancreatitis-vs-NoPancreatitis
7.724800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.921600E-02
Normal-vs-N1
1.258950E-01
N0-vs-N1
6.612400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.436260E-04
Normal-vs-TP53-NonMutant
1.118220E-01
TP53-Mutant-vs-TP53-NonMutant
2.0741999999907E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
